CF PHARMTECH: The Hong Kong public offering was subscribed 6,697.80 times, with a net fundraising of approximately HKD 525 million from the global offering

智通财经
2025.10.06 15:07

长风药业宣布其全球发售约 4119.8 万股股份，香港公开发售占 10%，国际发售占 90%。最终发售价为每股 14.75 港元，全球发售净筹约 5.25 亿港元。香港公开发售获 6697.80 倍认购，国际发售获 12.74 倍认购，预计将于 2025 年 10 月 8 日开始在联交所交易。

智通财经 APP 讯，长风药业 (02652) 发布公告，公司全球发售约 4119.8 万股股份，香港公开发售占 10%，国际发售占 90%。最终发售价为每股 14.75 港元，全球发售净筹约 5.25 亿港元。每手 500 股，预期将于 2025 年 10 月 8 日 (星期三) 上午九时正 (香港时间) 开始在联交所买卖。

其中，香港公开发售获 6697.80 倍认购，国际发售获 12.74 倍认购。

Source: 智通财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.